People · Operator
Named in public records as an officer, director or promoter · active 2013–2017 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NONO, Inc. | — | Biotechnology | Series A | $9.8M | $353.4M | 2013 |
| Arthritis Innovation Corp | — | Other Health Care | Pre-Seed | $324K | $10.0M | 2017 |
Mark Krembil at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Krembil on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Levitt | 1 | 1 |
| Glenys Foster-Roberts | 1 | 1 |
| Dr. Wayne Marshall | 1 | 1 |
| Nizar Mahomed | 1 | 1 |
| Joshua Josephson | 1 | 1 |
| Michael Tymianski | 1 | 1 |
| Michael Salter | 1 | 1 |
| Gregory Wolfond | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.